SCHEMBL31716338

SCHEMBL31716338

O=C(O)Cc1csc(-c2ccccn2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KB2 Q9UBS0 2/20 0.57
▸ KDM4E B2RXH2 4/20 0.48
▸ NPC1 O15118 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ GLA P06280 1/20 0.43
▸ THRA P10827 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ GABRP O00591 1/20 0.43
▸ GABRD O14764 1/20 0.43
▸ GABRA1 P14867 1/20 0.43
▸ GABRB1 P18505 1/20 0.43
▸ GABRG2 P18507 1/20 0.43
▸ GABRB3 P28472 1/20 0.43
▸ GABRA5 P31644 1/20 0.43
▸ GABRA3 P34903 1/20 0.43
▸ GABRA2 P47869 1/20 0.43
▸ GABRB2 P47870 1/20 0.43
▸ GABRA4 P48169 1/20 0.43
▸ GABRE P78334 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31716148 0.80 RPS6KB2 (0.46) RPS6KB2KDM4ENPC1MAPTRAB9A
SCHEMBL27613084 0.79 KDM4E (0.40) RPS6KB2KDM4ENPC1MAPTRAB9A
SCHEMBL27612819 0.75 KDM4E (0.42) KDM4ENPC1MAPTRAB9AGLA
SCHEMBL8357905 0.75 KDM4E (0.58) KDM4ETHRATHRBGABRPGABRD
SCHEMBL18473272 0.75 ADORA3 (0.52) KDM4ETHRATHRBGABRPGABRD
SCHEMBL27605065 0.75 KDM4E (0.49) KDM4ENPC1MAPTRAB9AGLA
SCHEMBL11387059 0.75 ADORA3 (0.55) KDM4ENPC1MAPTRAB9AKDM4A
SCHEMBL5663650 0.74 KDM4E (0.59) RPS6KB2KDM4ENPC1MAPTRAB9A
SCHEMBL538208 0.73 ABCC4 (0.61) KDM4EAKR1B1CES1GFERWNT3A
SCHEMBL30433544 0.73 ABCC4 (0.61) KDM4EAKR1B1CES1GFERWNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
Send feedback